Cancer therapies do not always succeed in eliminating tumor cells. Some of these cells enter a state of senescence—a latent, ...

A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical ...

The clinical approach, epidemiology, diagnostic procedures, and management, along with followup of superficial spreading malignant melanoma ... depending on tumor invasiveness and metastasis.

In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive disease by 46% and ...

Cancer incidence continues to rise for many common cancers—especially for women. The incidence rate for women younger than 50 ...

A study reveals that melanomas thicker than 0.8 mm are associated with a higher risk of melanoma-related death, highlighting ...